Cargando…

Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells

Focusing on defining metabolite-based inter-tumoral heterogeneity in ovarian cancer, we investigated the metabolic diversity of a panel of high-grade serous ovarian carcinoma (HGSOC) cell-lines using a metabolomics platform that interrogate 731 compounds. Metabolic fingerprinting followed by 2-dimen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Ji Hee, Jayaraman, Muralidharan, Nadhan, Revathy, Kashyap, Srishti, Mukherjee, Priyabrata, Isidoro, Ciro, Song, Yong Sang, Dhanasekaran, Danny N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698993/ https://www.ncbi.nlm.nih.gov/pubmed/34944743 http://dx.doi.org/10.3390/biomedicines9121927

Ejemplares similares

Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
por: Nadhan, Revathy, et al.
Publicado: (2023)

Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology
por: Nadhan, Revathy, et al.
Publicado: (2022)

GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer
por: Ha, Ji Hee, et al.
Publicado: (2021)

Identification of GNA12-driven gene signatures and key signaling networks in ovarian cancer
por: Ha, Ji-Hee, et al.
Publicado: (2021)

Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells
por: Ha, Ji Hee, et al.
Publicado: (2020)

Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets
por: Gomathinayagam, Rohini, et al.
Publicado: (2020)

Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer
por: Ha, Ji Hee, et al.
Publicado: (2016)

Hax-1 is required for Rac1-Cortactin interaction and ovarian carcinoma cell migration
por: Gomathinayagam, Rohini, et al.
Publicado: (2014)

Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth
por: Ha, Ji Hee, et al.
Publicado: (2015)

Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus
por: Ha, Ji Hee, et al.
Publicado: (2016)

The second annual conference of International ovarian cancer consortium and the symposium on tumor microenvironment and therapeutic resistance
por: Isidoro, Ciro, et al.
Publicado: (2016)

Glycolysis Inhibition of Autophagy Drives Malignancy in Ovarian Cancer: Exacerbation by IL-6 and Attenuation by Resveratrol
por: Vidoni, Chiara, et al.
Publicado: (2023)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer
por: Ferraresi, Alessandra, et al.
Publicado: (2020)

BECN1 and BRCA1 Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis
por: Salwa, Amreen, et al.
Publicado: (2021)

Resveratrol Contrasts IL-6 Pro-Growth Effects and Promotes Autophagy-Mediated Cancer Cell Dormancy in 3D Ovarian Cancer: Role of miR-1305 and of Its Target ARH-I
por: Esposito, Andrea, et al.
Publicado: (2022)

Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved
por: Vallino, Letizia, et al.
Publicado: (2020)

Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2015)

Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis
por: Gunderson, Camille C, et al.
Publicado: (2022)

The Molecular Fingerprint of High Grade Serous Ovarian Cancer Reflects Its Fallopian Tube Origin
por: Kessler, Mirjana, et al.
Publicado: (2013)

Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy
por: Ferraresi, Alessandra, et al.
Publicado: (2021)

Fingerprinting MINOCA: Unraveling Clues With Quantitative CMR
por: Lo Presti, Saberio, et al.
Publicado: (2023)

Ovarian Cancer
por: Song, Yong Sang, et al.
Publicado: (2014)

Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research
por: Cybula, Magdalena, et al.
Publicado: (2021)

KRAS‐Mutated, Estrogen Receptor‐Positive Low‐Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery
por: Kato, Shumei, et al.
Publicado: (2021)

Calorie Restriction for Cancer Prevention and Therapy: Mechanisms, Expectations, and Efficacy
por: Vidoni, Chiara, et al.
Publicado: (2021)

Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer
por: Jayaraman, Muralidharan, et al.
Publicado: (2017)

Cytological Grading of Breast Tumors—The Human and Canine Perspective
por: Kuppusamy, Krithiga, et al.
Publicado: (2019)

Editorial: Small molecules and peptides in paracrine/autocrine regulation of ovarian folliculogenesis
por: Kim, So-Youn, et al.
Publicado: (2023)

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
por: Santin, A D, et al.
Publicado: (2005)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Perspectives on mechanistic implications of ROS inducers for targeting viral infections
por: Nadhan, Revathy, et al.
Publicado: (2021)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
por: Asare-Werehene, Meshach, et al.
Publicado: (2019)

Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions
por: Yoon, Hyo-Jin, et al.
Publicado: (2021)

Unraveling bacterial fingerprints of city subways from microbiome 16S gene profiles
por: Walker, Alejandro R., et al.
Publicado: (2018)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_02gpdhkmossei5uld1oe71peho